bioRxiv / medRxivopen access
Variation in Tolvaptan Prescribing for Autosomal Dominant Polycystic Kidney Disease in the United Kingdom and Its Impact on Quality of Life and Costs
nephrology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 154939
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.